Publication

Byline

TMC's game will end Bengal's development will begin: CM Yogi

Jammu, April 20 -- JOYPUR (PURULIA), Apr 20: Chief Minister Yogi Adityanath on Monday addressed a massive public rally in the Joypur Assembly constituency of Purulia district in West Bengal, appealing... और पढ़ें


बड़ी बहन से झगड़ने के बाद किशोरी ने फांसी लगा जान दी

चित्रकूट, अप्रैल 20 -- चित्रकूट। सरधुआ थाना क्षेत्र के पनौटी गांव में रविवार की देर शाम बड़ी बहन से घरेलू कामकाज को लेकर झगड़ने के बाद किशोरी ने फांसी लगा ली। खेत से लौटे परिजनों ने उसे फंदे पर लटका पाय... और पढ़ें


Awareness Programme on 'Nasha Mukt Jammu Kashmir Abhiyan' Organised by SKUAST-Jammu

JAMMU, April 20 -- In line with the 100-day "Nasha Mukt Jammu Kashmir Abhiyan" launched by the Hon'ble Lieutenant Governor on April 11 to combat the growing drug menace, Sher-e-Kashmir University of A... और पढ़ें


Respecting heritage alongside development, Yogi govt shaping a New Identity for UP

LUCKNOW, April 20 -- Alongside accelerating development works in Uttar Pradesh, the Yogi government is consistently taking positive initiatives to honour the legacy of great personalities. While the s... और पढ़ें


Sadhotra expresses grief over Udhampur-Ramnagar road accident; seeks relief for victims

JAMMU, April 20 -- National Conference Additional General Secretary and former Minister Ajay Kumar Sadhotra on Monday expressed deep anguish and grief over the loss of twenty one lives and about thirt... और पढ़ें


Andhra CM Chandrababu Naidu slams DMK govt in Coimbatore

Coimbatore, April 20 -- Andhra Pradesh Chief Minister N Chandrababu Naidu, while campaigning in Coimbatore in support of NDA candidates, launched a sharp attack on the DMK government in Tamil Nadu. H... और पढ़ें


Singapore Clinical Trial: A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Investigator’s Choice of TKI Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Singapore, April 20 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... और पढ़ें


Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, April 20 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... और पढ़ें


Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, April 20 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... और पढ़ें


Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, April 20 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... और पढ़ें